Day: March 17, 2020

Wednesday March 18, 08:00 CETSEB will tomorrow participate at the Morgan Stanley European Financials Conference. In line with our ambition to be transparent to the market and treat all investors and analysts equally, Johan Torgeby, CEO and Masih Yazdi, CFO, will be available to answer questions via a telephone conference call tomorrow at 08:00 CET.To participate, please call +44 (0)2071 928 000, quote conference id: 6945197, at least 10 minutes in advance.The telephone conference will be available afterwards at sebgroup.com/ir  For further information, please contactChristoffer Geijer, Head of Investor Relations+46-8-763 83 19, +46-70-762 1006Frank Hojem, Head of Corporate Communication+46-8-763 99 47, +46-70-763 99 47SEB is a leading Nordic financial services group with a strong belief that entrepreneurial minds and innovative companies...

Onsdagen den 18 mars, 08:00SEB kommer imorgon att delta på Morgan Stanleys European Financials Conference. I enlighet med vår ambition att vara transparanta mot marknaden och behandla alla investerare och analytiker lika kommer Johan Torgeby, CEO och Masih Yazdi, CFO, att finnas tillgängliga för att besvara frågor via en telefonkonferens kl. 08:00 imorgon.  För att delta, ring 08-506 921 80, ange konferens-id: 6945197 , minst 10 minuter innan konferensen börjar.Telefonkonferensen kommer att finnas tillgänglig i efterhand på sebgroup.com/sv/ir.  För mer information kontaktaChristoffer Geijer, Chef för Investor Relations08-763 83 19, 070-762 10 06Frank Hojem,  Kommunikationschef08-763 99 47, 070-763 99 47SEB är en ledande nordisk finansiell koncern. Vi tror starkt på att entreprenöriellt tänkande och innovativa företag behövs för att skapa...

Highlights:Freia’s initial launch of 10,000 bottles of Dermogel in Italy, with the first batch of 4,000 bottles has been sold out within 5 days.Freia’s Manufacturing and supply chains are open, and another 34,000 units are being ordered for express delivery into Italy and 50,000 units on order from the UK.Dermogel has been clinically proven to sanitize hands and to be effective in reducing microbial and viral contaminants on the skin.MONTREAL, March 17, 2020 (GLOBE NEWSWIRE) — ELIXXER, LTD. (TSX.V: ELXR. OTCQB: ELIXF) (“ELXR” or the “Company”) announces that its Italian pharmaceutical partner, Freia Farmaceutici (Freia), has successfully launched its topical hand sanitizer, Dermogel, in Italy with their initial block of 10,000 units. The first batch of 4.000 bottles, from its first 10,000 unit manufacturing run, has been sold out...

                                               Form 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1.       KEY INFORMATIONINTERESTS AND SHORT POSITIONS Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)DEALINGS (Note 4) Purchases and sales(b)      Derivatives transactions (other than options transactions)(c)      Options transactions in respect of existing relevant securities(i)       Writing, selling, purchasing or varying(ii)      Exercising(d)      Other dealings (including transactions in respect of new securities) (Note 4)    2.      ...

La majorité des sujets potentiels ont été présélectionnés pour l’étudeL’EB-101 est produit avec succès par Abeona et transplanté au centre médical de l’université de StanfordNEW YORK et CLEVELAND, 17 mars 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq : ABEO), un chef de file entièrement intégré en thérapie génique et cellulaire, a annoncé aujourd’hui que des chercheurs du centre médical de l’université de Stanford avaient traité un premier patient dans le cadre de l’étude pivot de phase III VIITAL™ d’évaluation de l’EB-101, la thérapie cellulaire corrigée des gènes de la société pour l’épidermolyse bulleuse dystrophique récessive (EBDR).« Le traitement du premier patient de notre étude pivot de phase III VIITAL™ est une réalisation importante pour le programme EB-101,...

Marimekko Corporation, Stock Exchange Release, 17 March 2020 at 4.30 p.m.MARIMEKKO’S FINANCIAL STATEMENTS FOR 2019 ARE PUBLISHED Marimekko Corporation’s Financial Statements for 2019 have been published today. The publication includes the consolidated financial statements, the parent company financial statements, the Board of Directors’ report and the statement for non-financial information. Marimekko has also published the 2019 Corporate Governance Statement and Remuneration Statement. The Financial Statements and other published documents are attached to this release and are also available on Marimekko’s website company.marimekko.com. The printed Financial Statements will be available in week 15 at the latest, and the report can be ordered through Marimekko’s website.MARIMEKKO CORPORATION Corporate Communications Anna Tuominen Tel....

Marimekko Oyj, Pörssitiedote 17.3.2020 klo 16.30MARIMEKON TILINPÄÄTÖS 2019 ON JULKAISTU Marimekko Oyj:n vuoden 2019 tilinpäätös on julkaistu tänään. Tilinpäätösjulkaisu sisältää konsernitilinpäätöksen, emoyhtiön tilinpäätöksen, hallituksen toimintakertomuksen sekä selvityksen muista kuin taloudellisista tiedoista. Samalla Marimekko julkaisee selvityksen hallinto- ja ohjausjärjestelmästä sekä palkka- ja palkkioselvityksen. Tilinpäätös ja muut nyt julkaistavat dokumentit ovat tämän tiedotteen liitteenä, ja ne ovat luettavissa myös yhtiön kotisivuilla osoitteessa company.marimekko.com. Painettu tilinpäätös on saatavilla viimeistään viikolla 15 ja sen voi tilata yhtiön kotisivuilta. MARIMEKKO OYJKonserniviestintäAnna TuominenPuh. 040 584 6944anna.tuominen@marimekko.comJAKELU:Nasdaq Helsinki OyKeskeiset tiedotusvälineetMarimekko on suomalainen...

SEK TENDER OPERATION ANNOUNCEMENT 2020-03-18Result of the auction will be published at 11.45 (CET/CEST)Complete terms and conditions can be retrieved at http://www.riksbank.se 

Regulatory release 5/2020Following the postponement of several sports events in many countries including the UEFA EURO 2020 due to the outbreak of COVID-19, the sports betting media group, Better Collective, provides an extraordinary business update with the following highlights:Until mid March, Better Collective’s business has shown strong performance and has not been notably affected by postponements of sports events caused by the COVID-19 outbreak.In the last couple of days, major sports events have been postponed, leading to reduced sports betting activity to approximately half of normal levels. The esports and casino business have not been affected.The financial targets for 2020 remain unchanged until further, given certain assumptions. Better Collective’s business model and strong balance sheet allows for a high degree of flexibility...

Nasdaq Copenhagen                                                                               Nikolaj Plads 6DK-1067 Copenhagen K   Copenhagen, 17 March 2020STOCK EXCHANGE ANNOUNCEMENT no 11/2020Managers’ transactionsPursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 17 March 2020.Cemat A/SFrede ClausenChairmanThis announcement has been prepared in a Danish-language and an English-languageversion. In case of doubt, the Danish version prevails.AttachmentAnnouncement no. 11 – 17.03.2020